Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension studyJared M. Baeten, Samuel Albert, Daniel Szydlo et al.|The Lancet HIV|2021Cited by 111
Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair ConcentrationsCatherine A. Koss, Monica Gandhi, Peter Bacchetti et al.|AIDS Research and Human Retroviruses|2017Cited by 57